Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Included in UNGC 20 Case Examples of Sustainable Development for 20 Years Collection 2024-12-12 16:30
WuXi Biologics Launches WuXia™ RidGS for Non-Antibiotic Cell Line Development 2024-10-28 17:00
WuXi Biologics Receives ESG Corporate Platinum Award from The Asset for Fourth Consecutive Year 2024-10-16 20:00
WuXi Biologics Included in Hang Seng ESG 50 Index 2024-09-23 17:30
WuXi Biologics Reports Solid 2024 Interim Results 2024-08-21 23:46
WuXi Biologics and Medigene Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers 2024-08-08 16:00
WuXi Biologics' Four Manufacturing Facilities and Biosafety Testing Center Certified Again by European Medicines Agency for Ten Biologics 2024-08-01 15:00
WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year 2024-07-10 13:30
WuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment 2024-04-30 10:55
WuXi Biologics Reports Solid 2023 Annual Results 2024-03-26 21:53
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment 2024-03-05 21:00
WuXi Biologics Recognized as Both Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics 2024-02-21 18:00
WuXi Biologics Successfully Completes First 1,6000L Manufacturing Run in Ireland 2024-01-31 17:31
WuXi Biologics Launches WuXia ADCC PLUS™ for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect 2024-01-25 08:30
WuXi Biologics Granted U.S. Patent for Proprietary Bispecific Antibody Technology Platform WuXiBody™ 2024-01-17 08:30
WuXi Biologics to Increase Manufacturing Capacity in Massachusetts 2024-01-08 17:52
WuXi Biologics Named to 2023 Dow Jones Sustainability World Index 2023-12-12 17:00
WuXi Biologics Awarded Highest Platinum Medal by EcoVadis Sustainability Rating 2023-12-08 17:40
WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale 2023-11-22 13:21
WuXi Biologics Receives AAA MSCI ESG Rating 2023-11-08 08:30
1 2 3 4 5 9